Sugerencias de búsqueda
#premios #convocatorias #fipse #innovacion #proyectos #ayudas #contratación
Lo más buscado
Nanodecal´s technology overcomes bottlenecks in the diagnosis of respiratory disease that are precluding the prescription of precision therapies. Our solutions include new methods for obtaining, treating, and analyzing respiratory samples using user-friendly devices that can be implemented in any healthcare setting.
Thanks to funding from FIPSE we were able to obtain a regulatory roadmap for our technology. This information has been crucial in order to plan future development steps, increase the technology readiness level and advance towards commercialization.
Dispositivos médicos y sanitarios
- Estudios regulatorios y legales
Roberto de la Rica Quesada
Centro de investigación (Fundación Instituto de Investigación Sanitaria Illes Balears)
Looking for new team members with expertise in regulatory affairs, paper engineering, and company management to push this project forward.
The first medical device in Nanodecal’s pipeline aims at reducing the burden of respiratory infections caused by Pseudomonas aeruginosa. This superbug must be promptly eliminated with adequate antibiotics. Otherwise, it will generate biofilms that confer antimicrobial resistance.
Respiratory samples are highly viscous, which makes it challenging to analyze them with a rapid test. Nanodecal overcomes this difficulty with a proprietary method for liquefying respiratory samples on the spot. Detecting a single bacterial antigen limits the sensitivity of rapid tests. Nanodecal circumvents this issue with sensors that detect whole cells. Our tests do not need any instrumentation other than a smartphone equipped with our proprietary software for colorimetric signal reading.
¿Estás interesando en colaborar en este proyecto? Cumplimenta el siguiente cuestionario y nos pondrémos en contacto contigo.